Amyloidosis is a clinical disorder caused by extracellular or intracellular deposition of insoluble abnormal amyloid fibrils that affect the normal function of tissues.
This report contains market size and forecasts of Systemic Amyloidosis in Global, including the following market information:
Global Systemic Amyloidosis Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Systemic Amyloidosis market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Primary Systemic Amyloidosis (PSA) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Systemic Amyloidosis include Celgene Corporation(Bristol-Myers Squibb), Prothena Corporation PLC, TheraPharm Deutschland GmbH, Johnson & Johnson, Amgen Inc., Onclave Therapeutics Limited, Pfizer Inc., GlaxoSmithKline plc and Alnylam Pharmaceuticals, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Systemic Amyloidosis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Systemic Amyloidosis Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Systemic Amyloidosis Market Segment Percentages, by Type, 2021 (%)
Primary Systemic Amyloidosis (PSA)
Secondary Systemic Amyloidosis
Others
Global Systemic Amyloidosis Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Systemic Amyloidosis Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Research Institutes
Others
Global Systemic Amyloidosis Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Systemic Amyloidosis Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Systemic Amyloidosis revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Systemic Amyloidosis revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Celgene Corporation(Bristol-Myers Squibb)
Prothena Corporation PLC
TheraPharm Deutschland GmbH
Johnson & Johnson
Amgen Inc.
Onclave Therapeutics Limited
Pfizer Inc.
GlaxoSmithKline plc
Alnylam Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited
Allergan plc
AbbVie Inc.